Related Experiment Video
Updated: Apr 8, 2026

A Patient-Derived Xenograft Model for Venous Malformation
Published on: June 15, 2020
Polymorphisms of MMP9 and TIMP2 in Patients with Varicose Veins
Atike Tekeli Kunt1, Selim Isbir2, Uzay Gormus3
1Department of Cardiovascular Surgery, Kocaeli Derince Education and Research Hospital, Kocaeli, Turkey.
Background:
Genetic predisposition is a suggested risk factor in the etiology of varicose veins. The matrix metalloproteinase (MMP) family degrades extracellular matrix (ECM) and may lead to disturbances in vein wall structure. The activity of MMPs in the ECM are controlled by specific tissue inhibitors of MMPs (TIMP). The present study aimed to investigate the relationship between MMP9 and TIMP2 gene polymorphisms and varicose vein risk.
Materials And Methods:
Genotyping of the polymorphisms of MMP9 (1562 C/T) and TIMP2 (418G/C) was performed using polymerase chain reaction and restriction-fragment length polymorphism assays in a group of patients with varicose veins (n=63) and healthy controls (n=70).
Results:
The frequencies of MMP9 alleles and genotypes did not differ significantly between patient and control groups. However, TIMP2 -418 C allele was associated with increased risk for varicose vein formation (p=0.007). It was also shown that the frequency of the GG genotype was significantly higher in the control group than in the patient group (odds ratio=0.333, 95% confidence interval=0.14-0.78, p=0.012).
Conclusion:
TIMP2 -418 C allele is associated with susceptibility for varicose vein formation and individuals with GG genotype may have a lower risk for varicose vein formation.
Insights
Genetic variations in TIMP2, specifically the -418 C allele, are linked to an increased risk of developing varicose veins. The GG genotype may offer protection against varicose vein formation.
Area of Science:
- Genetics
- Vascular Biology
- Molecular Medicine
Background:
- Genetic predisposition is a suspected factor in varicose vein development.
- Matrix metalloproteinases (MMPs) degrade extracellular matrix (ECM), potentially affecting vein wall integrity.
- Tissue inhibitors of MMPs (TIMPs) regulate MMP activity.
Purpose of the Study:
- To investigate the association between matrix metalloproteinase 9 (MMP9) and tissue inhibitor of metalloproteinase 2 (TIMP2) gene polymorphisms and the risk of varicose veins.
Main Methods:
- Genotyping of MMP9 (1562 C/T) and TIMP2 (418G/C) polymorphisms using PCR and RFLP.
- Study included 63 patients with varicose veins and 70 healthy controls.
Main Results:
- No significant difference in MMP9 allele or genotype frequencies between patients and controls.
- The TIMP2 -418 C allele was associated with an increased risk of varicose vein formation (p=0.007).
- The TIMP2 GG genotype was significantly more frequent in controls, suggesting a protective effect (OR=0.333, p=0.012).
Conclusions:
- The TIMP2 -418 C allele is linked to increased susceptibility to varicose veins.
- Individuals with the TIMP2 GG genotype may have a reduced risk of developing varicose veins.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Role of Matrix Metalloproteases in Degradation of ECM
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Varicose Veins I: Introduction
Mitral Valve Prolapse I: Introduction

